PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Aug 20, 2026, 10:30 AM

Lupin and Tenpoint Therapeutics Partner to Commercialize YUVEZZI in Key European Markets for Presbyopia

Shots: Ref: Lupin | Image: Lupin & Tenpoint| Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Lupin and Tenpoint Therapeutics Partner to Commercialize YUVEZZI in Key European Markets for Presbyopia appeared first on PharmaShots.

ET Pharma

Aug 20, 2026, 10:01 AM

Lupin licenses Tenpoint Therapeutics’ presbyopia therapy Europe market rights

Under the agreement, Lupin’s wholly owned subsidiary VISUfarma will make a strategic investment in Visus and the company will also be eligible to receive regulatory and commercial milestone payments, as well as tiered royalties based on net sales.

Pharma Tech

Aug 20, 2026, 9:40 AM

FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy

Ultragenyx Pharmaceutical has received accelerated approval from the FDA for its gene therapy, Genglycos, to treat GSDIa.

Pharma Tech

Aug 20, 2026, 8:51 AM

SandboxAQ introduces AQPotency for virtual drug screening

SandboxAQ has introduced AQPotency, a LQM designed to virtually screen and predict the potential of drug candidates without the need for a solved protein structure.

PharmaShots

Aug 20, 2026, 8:30 AM

Tolerance Bio Licenses Efineptakin Alfa from NeoImmuneTech to Advance Thymic Function and Immune Resilience Programs

Shots: Ref: Tolerance Bio | Image: Tolerance Bio | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com The post Tolerance Bio Licenses Efineptakin Alfa from NeoImmuneTech to Advance Thymic Function and Immune Resilience Programs appeared first on PharmaShots.

ET Pharma

Aug 20, 2026, 8:13 AM

Mankind licenses Insulin Degludec and Aspart combo from China’s Chenan Bio

The licensed drugs are alternatives to Novo Nordisk’s Tresiba and Ryzodeg. Both biosimilar therapies have completed their Phase 3 studies in China.

News

Latest industry coverage

Google News

Aug 20, 2026, 10:30 AM

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move - Forbes

Italy’s $10 Billion Pharma Family Makes A U.S. Power Move  Forbes

Google News

Aug 20, 2026, 10:17 AM

Danish firm Novonesis to roll out ₹3,000 crore Maharashtra investment over 2-3 years - The Economic Times

Danish firm Novonesis to roll out ₹3,000 crore Maharashtra investment over 2-3 years  The Economic Times

Google News

Aug 20, 2026, 10:15 AM

FDA to host workshop for companies exploring the GLP-1 generic drug pathway - PharmaLive

FDA to host workshop for companies exploring the GLP-1 generic drug pathway  PharmaLive

Google News

Aug 20, 2026, 10:14 AM

PharmaTech Expo brings together over 450 exhibitors, 10,000 products in Gandhinagar - The Tribune

PharmaTech Expo brings together over 450 exhibitors, 10,000 products in Gandhinagar  The Tribune

Google News

Aug 20, 2026, 10:05 AM

Job losses, plant closures spark talks on future of SA’s pharmaceutical industry - Business Day

Job losses, plant closures spark talks on future of SA’s pharmaceutical industry  Business Day

Google News

Aug 20, 2026, 10:03 AM

The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi - Pharmaceutical Executive

The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi  Pharmaceutical Executive

Google News

Aug 20, 2026, 10:01 AM

Lab 4.0 balance: connected, compliant and ready to integrate - European Pharmaceutical Review

Lab 4.0 balance: connected, compliant and ready to integrate  European Pharmaceutical Review

Google News

Aug 20, 2026, 9:37 AM

IFC, Popular Pharmaceuticals Partner to Boost Bangladesh’s Healthcare Supply Chains and Create Jobs - fundsforNGOs News

IFC, Popular Pharmaceuticals Partner to Boost Bangladesh’s Healthcare Supply Chains and Create Jobs  fundsforNGOs News

Google News

Aug 20, 2026, 9:18 AM

Pharmaceutical production compliance burdens nobody talks about - Cleanroom Technology

Pharmaceutical production compliance burdens nobody talks about  Cleanroom Technology

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer